U.S. flag

An official website of the United States government

NM_144988.4(ALG14):c.326G>A (p.Arg109Gln) AND Congenital myasthenic syndrome 15

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Apr 11, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000688360.4

Allele description [Variation Report for NM_144988.4(ALG14):c.326G>A (p.Arg109Gln)]

NM_144988.4(ALG14):c.326G>A (p.Arg109Gln)

Gene:
ALG14:ALG14 UDP-N-acetylglucosaminyltransferase subunit [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p21.3
Genomic location:
Preferred name:
NM_144988.4(ALG14):c.326G>A (p.Arg109Gln)
Other names:
ALG14, ARG109GLN (rs199689080)
HGVS:
  • NC_000001.11:g.95027223C>T
  • NG_042044.1:g.50729G>A
  • NM_001305242.2:c.363G>A
  • NM_144988.4:c.326G>AMANE SELECT
  • NP_001292171.1:p.Pro121=
  • NP_659425.1:p.Arg109Gln
  • NC_000001.10:g.95492779C>T
  • NM_144988.3:c.326G>A
  • NR_131032.2:n.227G>A
Protein change:
R109Q; ARG109GLN
Links:
OMIM: 612866.0006; dbSNP: rs199689080
NCBI 1000 Genomes Browser:
rs199689080
Molecular consequence:
  • NM_144988.4:c.326G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_131032.2:n.227G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001305242.2:c.363G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Congenital myasthenic syndrome 15
Synonyms:
Myasthenic syndrome, congenital, 15, without tubular aggregates
Identifiers:
MONDO: MONDO:0014542; MedGen: C4015596; Orphanet: 353327; Orphanet: 590; OMIM: 616227

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000815968Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 23, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV004049475Genome-Nilou Lab
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Apr 11, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Early and lethal neurodegeneration with myasthenic and myopathic features: A new ALG14-CDG.

Schorling DC, Rost S, Lefeber DJ, Brady L, Müller CR, Korinthenberg R, Tarnopolsky M, Bönnemann CG, Rodenburg RJ, Bugiani M, Beytia M, Krüger M, van der Knaap M, Kirschner J.

Neurology. 2017 Aug 15;89(7):657-664. doi: 10.1212/WNL.0000000000004234. Epub 2017 Jul 21.

PubMed [citation]
PMID:
28733338
PMCID:
PMC5562963

A novel ALG14 missense variant in an alive child with myopathy, epilepsy, and progressive cerebral atrophy.

Palombo F, Piccolo B, Saccani E, Fiorini C, Capristo M, Caporali L, Pisani F, Carelli V.

Am J Med Genet A. 2021 Jun;185(6):1918-1921. doi: 10.1002/ajmg.a.62153. Epub 2021 Mar 10. No abstract available.

PubMed [citation]
PMID:
33751823
See all PubMed Citations (4)

Details of each submission

From Invitae, SCV000815968.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 109 of the ALG14 protein (p.Arg109Gln). This variant is present in population databases (rs199689080, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of ALG14-congenital disorder of glycosylation (PMID: 28733338, 33751823). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 379351). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Genome-Nilou Lab, SCV004049475.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023